oropharyngeal SCC
Showing 1 - 25 of 702
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Recruiting
- HPV
- Oropharyngeal Squamous Cell Carcinoma
- Screening
-
Boston, MassachusettsDana Farber Cancer Institute
Jun 8, 2022
Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)
Not yet recruiting
- Oropharyngeal Cancer
- +10 more
- Fludarabine
- +2 more
- (no location specified)
Dec 14, 2022
Oropharyngeal Squamous Cell Carcinoma (SCC) Trial run by the National Cancer Institute (NCI) (PRGN-2009, Pembrolizumab)
Not yet recruiting
- Oropharyngeal Squamous Cell Carcinoma (SCC)
- PRGN-2009
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 22, 2023
Carcinoma, Squamous Cell, Head and Neck Tumors, Oropharyngeal Tumors Trial in United States (radiation, drug, procedure)
Active, not recruiting
- Carcinoma, Squamous Cell
- +2 more
- Intensity Modulated Radiotherapy (IMRT)
- +2 more
-
Gainesville, Florida
- +4 more
Dec 15, 2021
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Oropharyngeal Squamous Cell Carcinoma Trial in Worldwide (Radiation, Cisplatin, Durvalumab)
Recruiting
- Oropharyngeal Squamous Cell Carcinoma
- Radiation
- +3 more
-
Brussels, Belgium
- +25 more
Aug 8, 2022
Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)
Active, not recruiting
- Laryngeal Cancer Stage II
- +3 more
- radiotherapy
- Olaparib
-
Amsterdam, NetherlandsThe Netherlands Cancer Institute
Sep 27, 2022
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- cetuximab
- +3 more
-
Newark, New JerseyNew Jersey Medical School
Apr 19, 2021
Squamous Cell Carcinoma of Head and Neck Trial in France (bintrafusp alfa)
Terminated
- Squamous Cell Carcinoma of Head and Neck
- bintrafusp alfa
-
Bordeaux, France
- +7 more
Mar 28, 2022
Head Neck Cancer Trial (Whole genomic DNA/RNA tumour sequencing)
Not yet recruiting
- Head and Neck Cancer
- Whole genomic DNA/RNA tumour sequencing
- (no location specified)
May 9, 2022
IMaC - Immune Pathways in Oesophagogastric Cancer
Not yet recruiting
- Oesophagogastric Cancer
- No intervention sample collection only
-
Guildford, United Kingdom
- +2 more
Oct 4, 2023
Oropharyngeal Cancer, Squamous Cell Carcinoma, Human Papilloma Virus Trial in Philadelphia (Radiation Therapy (IMRT or IMPT))
Recruiting
- Oropharyngeal Cancer
- +2 more
- Radiation Therapy (IMRT or IMPT)
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 8, 2021
Smoking Cessation, Nursing Education Trial in Hong Kong (A designed empathy intervention, Smoking cessation counseling tutorial)
Not yet recruiting
- Smoking Cessation
- Nursing Education
- A designed empathy intervention
- Smoking cessation counseling tutorial
-
Hong Kong, Hong KongThe University of Hong Kong
May 8, 2023
HPV Associated Anogenital Pathology in Female Patients and
Recruiting
- Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 2, 2023
End of Life, Cancer Trial in United States (Receive technology-based supportive cancer care, Receive redesigned team-based
Recruiting
- End of Life
- Cancer
- Receive technology-based supportive cancer care
- Receive redesigned team-based supportive cancer care
-
Birmingham, Alabama
- +16 more
Jun 23, 2022
Hypoxia, Gastric Polyp, Colon Cancer Trial in China (the COMBO Endoscopy Oropharyngeal Airway, Regular Nasal Cannula)
Not yet recruiting
- Hypoxia
- +3 more
- the COMBO Endoscopy Oropharyngeal Airway
- Regular Nasal Cannula
-
Nanjing, Jiangsu, China
- +5 more
Oct 7, 2023
Gastric Insufflation, Difficult Mask Ventilation Trial in Ankara (nasal airway, oral airway)
Not yet recruiting
- Gastric Insufflation
- Difficult Mask Ventilation
- nasal airway
- oral airway
-
Ankara, TurkeyAnkara Etlik City Hospital
Apr 15, 2023
Artificial Intelligence Patient App for RDEB SCCs
Recruiting
- Epidermolysis Bullosa Dystrophica
- online survey
-
Chicago, IllinoisDepartment of Dermatology, Northwestern University Feinberg Scho
May 3, 2023
Obstructive Sleep Apnea of Adult Trial in Tainan (Oropharyngeal Exercises, Mandibular advancement device)
Not yet recruiting
- Obstructive Sleep Apnea of Adult
- Oropharyngeal Exercises
- Mandibular advancement device
-
Tainan, TaiwanNational Cheng Kung University Hospital
Oct 24, 2023
Squamous Cell Carcinoma of the Head and Neck T1/2N0-2 Trial in Dallas (Intensity Modulated Radiotherapy)
Terminated
- Squamous Cell Carcinoma of the Head and Neck T1/2N0-2
- Intensity Modulated Radiotherapy
-
Dallas, TexasUniversity of Texas at Southwestern Medical Center
Jan 28, 2021
Head Neck Cancer, Head and Neck Carcinoma, Head and Neck Tumors Trial in United States (diagnostic test, radiation, drug)
Recruiting
- Head and Neck Cancer
- +3 more
- 18F-FMISO PET/CT scan
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Sep 15, 2022
The Microbiome of Oesophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Cancer
- Microbial Colonization
- Upper endoscopy
-
Hong Kong, Hong KongPrince of Wales Hospital
Aug 15, 2022
Dysphagia, Oropharyngeal, Cerebral Palsy Trial in Tanta (Kinesio tape)
Recruiting
- Dysphagia, Oropharyngeal, Cerebral Palsy
- Kinesio tape
-
Tanta, EgyptHadeer samy abd elaziz
Nov 27, 2023
or Chemoradiotherapy Patient Care in Oropharyngeal Cancer
Recruiting
- Oropharyngeal Carcinoma
- Electronic Health Record Review
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Autism Spectrum Disorder, Social Communication Challenges Trial (APERS-based model)
Not yet recruiting
- Autism Spectrum Disorder
- Social Communication Challenges
- APERS-based model
- (no location specified)
Aug 16, 2022